T1	Disorder 9 38	Bulbar and pseudobulbar palsy
T2	Pharmacological_substance 75 95	cytosine arabinoside
N1000 	Reference T2 MeSH:D003561	cytosine arabinoside
T3	Disorder 113 121	leukemia
N1 	Reference T3 UMLS:C0023418	leukemia
T4	Pharmacological_substance 161 181	cytosine arabinoside
N1001 	Reference T4 MeSH:D003561	cytosine arabinoside
T5	Disorder 332 349	cerebellar ataxia
N2 	Reference T5 UMLS:C0007758	cerebellar ataxia
T6	Disorder 374 403	bulbar and pseudobulbar palsy
T7	Disorder 583 596	Neurotoxicity
N3 	Reference T7 UMLS:C0235032	Neurotoxicity
T8	Subject 99 107	children
T11	Subject 133 144	38 children
T12	Disorder 225 237	complication
N4 	Reference T12 UMLS:C0009566	complication
T14	Disorder 239 260	Neurological problems
N5 	Reference T14 UMLS:C0221571	Neurological problems
T15	Coreferring_mention 305 317	this therapy
T17	Pharmacological_substance 635 643	cytosine
N1002 	Reference T17 MeSH:D003596	cytosine
T19	Speculation_cue 597 600	can
T22	Speculation_cue 408 425	not been reported
